[EN] SUBSTITUTED GLYCINE DERIVATIVES FOR USE AS MEDICAMENTS<br/>[FR] DERIVES DE GLYCINE SUBSTITUES SERVANT DE MEDICAMENTS
申请人:PFIZER LTD
公开号:WO2004016583A1
公开(公告)日:2004-02-26
The compounds of formula (I) are substituted glycine derivatives useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, sleep disorders, visceral pain disorders and gastrointestinal disorders. Processes for the preparation of the final products and intermediates useful in the process are included. Pharmaceutical compositions containing one or more of the compounds are also included. Formula (I) wherein R' is hydroxycarbonyl, a carboxylic acid biostere or prodrug thereof; R3, R3a, R2 and R2a are independently selected from H, C1-C6 alkyl, and Cl-C6 alkoxy Cl-C6 alkyl.
公式(I)的化合物是取代甘氨酸衍生物,可用于治疗癫痫、晕厥发作、运动减少、颅脑疾病、神经退行性疾病、抑郁症、焦虑症、恐慌症、疼痛、关节炎、神经病理学疾病、睡眠障碍、内脏疼痛疾病和胃肠疾病。包括用于制备最终产品和在过程中有用的中间体的方法。还包含含有一种或多种化合物的药物组合物。公式(I)中,R'是羟碳酰基,羧酸的生物立体异构体或前药;R3、R3a、R2和R2a独立地选自H、C1-C6烷基和Cl-C6烷氧基Cl-C6烷基。